Valuation: Camurus AB

Market Cap 37.07B 3.88B 3.36B 3.15B 2.88B 5.41B 370B 5.49B 14.49B 185B 14.58B 14.26B 618B P/E 2026 *
38.7x
P/E 2027 * 25.1x
Enterprise Value 32.56B 3.41B 2.95B 2.77B 2.52B 4.75B 325B 4.82B 12.73B 163B 12.8B 12.52B 543B EV / Sales 2026 *
11.4x
EV / Sales 2027 * 8.34x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+1.44%
1 week+4.38%
Current month+2.19%
1 month+17.40%
3 months+22.76%
6 months+14.00%
Current year+2.44%
1 week 594.5
Extreme 594.5
633
1 month 525.5
Extreme 525.5
645
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 279.2
Extreme 279.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap.
07/08/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+1.44%+4.38%-2.09%+102.76% 3.88B
+0.43%+4.31%+90.84%+130.99% 1,088B
+0.41%+1.27%+50.98%+50.05% 629B
-0.53%+1.04%+25.23%+63.46% 440B
-0.41%-0.30%+45.61%+37.29% 359B
-0.31%-0.97%+27.11%+36.34% 291B
-0.54%-1.72%+1.77%+4.79% 245B
+0.45%+2.05%+46.04%+58.54% 225B
-0.81%+1.40%-8.65%-51.93% 204B
+0.07%+3.12%+13.21%+69.84% 168B
Average +0.02%+1.68%+29.00%+50.21% 365.31B
Weighted average by Cap. +0.02%+1.93%+48.58%+66.16%

Financials

2026 *2027 *
Net sales 2.86B 299M 259M 243M 222M 416M 28.54B 423M 1.12B 14.29B 1.12B 1.1B 47.65B 3.75B 393M 340M 319M 291M 546M 37.44B 555M 1.47B 18.75B 1.47B 1.44B 62.51B
Net income 949M 99.4M 86.12M 80.69M 73.6M 138M 9.48B 140M 371M 4.75B 373M 365M 15.83B 1.45B 152M 132M 123M 113M 212M 14.51B 215M 568M 7.26B 571M 559M 24.22B
Net Debt -4.52B -473M -410M -384M -350M -659M -45.13B -669M -1.77B -22.6B -1.78B -1.74B -75.34B -5.81B -608M -527M -494M -450M -847M -58.01B -860M -2.27B -29.05B -2.28B -2.23B -96.86B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
13/08/26 SEK 631.50 +1.36% 6,141
12/08/26 SEK 623.00 +0.16% 57,268
11/08/26 SEK 622.00 +2.13% 74,971
10/08/26 SEK 609.00 +0.33% 91,743
07/08/26 SEK 607.00 +0.41% 63,609
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
623.00SEK
Average target price
793.00SEK
Spread / Average Target
+27.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock